CORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of Daniel Curran, MD, to its Board of Directors.
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
Seeking Alpha / 1 hour from now 1 Views
Comments